Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Surgery|April 1, 1995
Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitisK Mithöfer, C Fernández-del Castillo, T W Frick, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 1, 1987
Effects of insecticide, diazinon, on pancreas of dog, cat and guinea pigT W Frick, S Dalo, J F O'Leary, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusL W Frick, L St John, L C Taylor, et al.
Plos One|May 3, 2014
Filtration improves the performance of a high-throughput screen for anti-mycobacterial compoundsNancy Cheng, Melissa A Porter, Lloyd W Frick, et al.
Journal of Medicinal Chemistry|February 5, 1993
Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virusC L Burns, M H St Clair, L W Frick, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineP A Furman, M Davis, D C Liotta, et al.
Clinical Transplants|January 1, 1995
Twenty-seven years of liver transplantation at Addenbrooke's Hospital, CambridgeG J Toogood, T W Frick, N V Jamieson, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 25, 2000
Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94)J H Chan, S D Chamberlain, K K Biron, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 25, 2024
Facilitators and barriers to adolescent participation in a TB clinical trialJ M Mangan, K N C Hedges, M M Salerno, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
Pageof 8